Covid vaccines help Pfizer, BioNTech, Sinovac, Moderna topple powerhouses GSK, Merck, Sanofi
While Pfizer became the largest seller of vaccines in 2021, the second and third spots were taken by BioNTech and Sinovec.
moderna
December 2022
December 2021
November 2021
July 2021
May 2021
February 2021
January 2021
The Conversation: Bernard Charlès, VC & CEO, Dassault Systèmes
Dassault Systèmes — French major whose software Boeing utilized for the design of 777 aircraft, is one of the world’s leading providers of design tools and software with revenues of €4.86 bn (2021).
55 Indian pharma cos capable of mRNA vaccines
Almost every major Indian pharmaceutical company, including Cipla, Dr Reddy’s, Sun Pharma and Biocon, are on the list of companies which can produce mRNA Covid-19 vaccines
Vaccine cos, scientists in war mode to tame Omicron coronavirus
The quartet of vaccine-makers from the western world are ascertaining the need to tweak their vaccines for the Omicron, whereas WHO states it is too early to comment on its virulence.
Mix and match vaccines, says Kiran Mazumdar-Shaw
In an exclusive conversation with Fortune India, the executive chairperson of Biocon says India should immediately start mixing and matching existing vaccines to accelerate the vaccination drive.
Scarcity-hit India looks for imported vaccines
At a time when the entire world is frantically trying to procure more vaccine doses, it is going to be a protracted struggle for India.
How Godrej joined the global vaccination drive
Godrej & Boyce has built an array of made-in-India ultra-low temperature freezers for the world.
Covid-19 vaccines: India to face a problem of plenty
Prices of vaccines may crash in the next few months. The vaccine makers will have to strike while the iron is hot.
With five vaccines, Serum set for global race
Besides Covishield, four more Covid-19 vaccines are under preparation at the world’s largest vaccine company in Pune as demand from across the globe spikes.
Hope floats for Covid-19 vaccine candidates in India
The DCGI has given the nod for two vaccines and phase 1 of the vaccination process is expected to begin soon. Zydus Cadila’s vaccine candidate has also been cleared for phase 3 trials.
